Diagnoses Disease
104
4
7
52
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
52 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.0%
1 terminated out of 104 trials
98.1%
+11.6% vs benchmark
0%
0 trials in Phase 3/4
4%
2 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (104)
Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
Measuring Skin Elasticity in Lymphedema Patients
Asthma Diagnosis Verified by Lung Function
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
GP Response to Decontextualised Risk
TB-CAPT EXULTANT - HIV
TB-CAPT CORE Truenat Trial
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Optimizing Bronchopulmonary Cancer Screening
Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema
Artificial Intelligence for Highly Myopic Cataract
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
TB-CAPT MTB/XDR Study
Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
Evaluation of the HARM for the Detection of a Cerebral Ischemia in TIA/TNA Patients
Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing